1. Home
  2. PHG vs NTRA Comparison

PHG vs NTRA Comparison

Compare PHG & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHG
  • NTRA
  • Stock Information
  • Founded
  • PHG 1891
  • NTRA 2003
  • Country
  • PHG Netherlands
  • NTRA United States
  • Employees
  • PHG N/A
  • NTRA N/A
  • Industry
  • PHG Medical Electronics
  • NTRA Medical Specialities
  • Sector
  • PHG Health Care
  • NTRA Health Care
  • Exchange
  • PHG Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • PHG 22.7B
  • NTRA 21.9B
  • IPO Year
  • PHG N/A
  • NTRA 2015
  • Fundamental
  • Price
  • PHG $26.15
  • NTRA $138.90
  • Analyst Decision
  • PHG Buy
  • NTRA Strong Buy
  • Analyst Count
  • PHG 2
  • NTRA 16
  • Target Price
  • PHG N/A
  • NTRA $185.56
  • AVG Volume (30 Days)
  • PHG 934.5K
  • NTRA 1.3M
  • Earning Date
  • PHG 07-29-2025
  • NTRA 08-07-2025
  • Dividend Yield
  • PHG 3.15%
  • NTRA N/A
  • EPS Growth
  • PHG N/A
  • NTRA N/A
  • EPS
  • PHG 0.43
  • NTRA N/A
  • Revenue
  • PHG $19,433,635,964.00
  • NTRA $1,831,000,000.00
  • Revenue This Year
  • PHG $3.83
  • NTRA $19.75
  • Revenue Next Year
  • PHG $4.10
  • NTRA $16.04
  • P/E Ratio
  • PHG $61.02
  • NTRA N/A
  • Revenue Growth
  • PHG N/A
  • NTRA 51.50
  • 52 Week Low
  • PHG $21.48
  • NTRA $92.14
  • 52 Week High
  • PHG $32.91
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • PHG 72.99
  • NTRA 30.96
  • Support Level
  • PHG $24.30
  • NTRA $136.91
  • Resistance Level
  • PHG $24.79
  • NTRA $142.49
  • Average True Range (ATR)
  • PHG 0.37
  • NTRA 5.08
  • MACD
  • PHG 0.19
  • NTRA -1.82
  • Stochastic Oscillator
  • PHG 98.97
  • NTRA 7.18

About PHG Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: